A pilot study of mifepristone in combat-related PTSD

Depression Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Golier, Julia A ^a,b   Caramanica, Kimberly ^a   Demaria, Rebecca ^a   Yehuda, Rachel ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873852800     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2012/393251     Document Type: Article

References (12)

1. Sarkar N. N., Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. European Journal of Obstetrics Gynecology and Reproductive Biology 2002 101 2 113 120 10.1016/S0301-2115(01)00522-X (Pubitemid 34163254)
2. Karssen A. M., Belanoff J. K., de Kloet E. R., Glucocorticoid receptor antagonist C-1073 (mifepristone/RU486) inhibits P-glycoprotein-mediated efflux transport of cortisol. Proceedings of the 34th Congress of International Society of Psychoneuroendocrinology 2003 New York, NY, USA
3. Belanoff J. K., Rothschild A. J., Cassidy F., DeBattista C., Baulieu E. E., Schold C., Schatzberg A. F., An open label trial of C-1073 (mifepristone) for psychotic major depression. Biological Psychiatry 2002 52 5 386 392 2-s2.0-0036752158 10.1016/S0006-3223(02)01432-4 (Pubitemid 35266729)
4. Buckley T., Duggal V., Schatzberg A. F., The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study. Journal of Clinical Sleep Medicine 2008 4 3 235 241 2-s2.0-47849104201 (Pubitemid 352039434)
5. Yehuda R., Golier J. A., Yang R. K., Tischler L., Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biological Psychiatry 2004 55 11 1110 1116 2-s2.0-2542423960 10.1016/j.biopsych.2004.02.010 (Pubitemid 38680564)
6. Bremner J. D., Licinio J., Darnell A., Krystal J. H., Owens M. J., Southwick S. M., Nemeroff C. B., Charney D. S., Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. American Journal of Psychiatry 1997 154 5 624 629 2-s2.0-0031004906 (Pubitemid 27197594)
7. Baker D. G., West S. A., Nicholson W. E., Ekhator N. N., Kasckow J. W., Hill K. K., Bruce A. B., Orth D. N., Geracioti T. D., Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. American Journal of Psychiatry 1999 156 4 585 588 2-s2.0-0032905877 (Pubitemid 29162980)
8. Young A. H., Gallagher P., Watson S., Del-Estal D., Owen B. M., Ferrier I. N., Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004 29 8 1538 1545 2-s2.0-3242783282 10.1038/sj.npp.1300471 (Pubitemid 38982247)
9. Gallagher P., Watson S., Smith M. S., Ferrier I. N., Young A. H., Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia. Biological Psychiatry 2005 57 2 155 161 2-s2.0-11844302940 10.1016/j.biopsych.2004.10.017 (Pubitemid 40094715)
10. DeBattista C., Belanoff J., Glass S., Khan A., Horne R. L., Blasey C., Carpenter L. L., Alva G., Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biological Psychiatry 2006 60 12 1343 1349 2-s2.0-33750483274 10.1016/j.biopsych.2006.05.034 (Pubitemid 44838535)
11. Nikzad S., Vafaei A. A., Rashidy-Pour A., rashidy-pour@sem-ums.ac.ir Haghighi S., Systemic and intrahippocampal administrations of the glucocorticoid receptor antagonist RU38486 impairs fear memory reconsolidation in rats. Stress 2011 14 4 459 464 10.3109/10253890.2010.548171
12. Rearte B., Maglioco A., Balboa L., Bruzzo J., Landoni V. I., Laborde E. A., Chiarella P., Ruggiero R. A., Fernández G. C., Isturiz M. A., Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clinical and experimental immunology 2010 162 3 568 577